Clinical Trial Update: Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus

View source ↗

Summary

This post-marketing safety study in heart transplant recipients receiving everolimus has been completed. The update summarizes safety data collected during the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis | Conditions: Coronary Heart Disease | Status: COMPLETED